Amneal Pharmaceuticals LLC

Contributing Author

Recent Articles by Amneal Pharmaceuticals LLC

May-29	Amneal to Participate at Upcoming Investor Conferences in June AMRX GlobeNewswire
May-15	Amneal Receives U.S. FDA Approval for Brekiya (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults AMRX GlobeNewswire
May-08	Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S. AMRX GlobeNewswire